Jobe A, Vijayan R
Front Pharmacol. 2024; 15:1349097.
PMID: 38495099
PMC: 10941346.
DOI: 10.3389/fphar.2024.1349097.
Bader M, Steckelings U, Alenina N, Santos R, Ferrario C
Hypertension. 2024; 81(5):964-976.
PMID: 38362781
PMC: 11023806.
DOI: 10.1161/HYPERTENSIONAHA.123.21364.
Franco R, Serrano-Marin J, Navarro G, Rivas-Santisteban R
Antioxidants (Basel). 2023; 12(10).
PMID: 37891948
PMC: 10604245.
DOI: 10.3390/antiox12101869.
Molaei A, Molaei E, Wallace Hayes A, Karimi G
Cell Cycle. 2023; 22(13):1654-1674.
PMID: 37365840
PMC: 10361149.
DOI: 10.1080/15384101.2023.2228089.
Schmitz G, Roth B
Am J Physiol Cell Physiol. 2023; 325(1):C17-C28.
PMID: 37067459
PMC: 10281788.
DOI: 10.1152/ajpcell.00397.2022.
Whole exome sequencing identifies a rare variant in MAS1 gene in a subject with lethal COVID-19.
Azzara A, Cassano I, Tirindelli M, Nobile C, Schittone V, Paccagnella E
Gene Rep. 2022; 29:101705.
PMID: 36348959
PMC: 9633625.
DOI: 10.1016/j.genrep.2022.101705.
Angiotensin-(1-7) improves cognitive function and reduces inflammation in mice following mild traumatic brain injury.
Bruhns R, Sulaiman M, Gaub M, Bae E, Davidson Knapp R, Larson A
Front Behav Neurosci. 2022; 16:903980.
PMID: 35990729
PMC: 9386567.
DOI: 10.3389/fnbeh.2022.903980.
The therapeutic potential of the novel angiotensin-converting enzyme 2 in the treatment of coronavirus disease-19.
Oyagbemi A, Ajibade T, Aboua Y, Gbadamosi I, Adedapo A, Obemisola Aro A
Vet World. 2021; 14(10):2705-2713.
PMID: 34903929
PMC: 8654738.
DOI: 10.14202/vetworld.2021.2705-2713.
ACE2 in the Gut: The Center of the 2019-nCoV Infected Pathology.
Guo Y, Wang B, Gao H, Gao L, Hua R, Xu J
Front Mol Biosci. 2021; 8:708336.
PMID: 34631794
PMC: 8493804.
DOI: 10.3389/fmolb.2021.708336.
The counter regulatory axis of the renin angiotensin system in the brain and ischaemic stroke: Insight from preclinical stroke studies and therapeutic potential.
McFall A, Nicklin S, Work L
Cell Signal. 2020; 76:109809.
PMID: 33059037
PMC: 7550360.
DOI: 10.1016/j.cellsig.2020.109809.
Advances in Understanding the Initial Steps of Pruritoceptive Itch: How the Itch Hits the Switch.
Kahremany S, Hofmann L, Gruzman A, Cohen G
Int J Mol Sci. 2020; 21(14).
PMID: 32664385
PMC: 7402353.
DOI: 10.3390/ijms21144883.
Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.
Arendse L, Danser A, Poglitsch M, Touyz R, Burnett Jr J, Llorens-Cortes C
Pharmacol Rev. 2019; 71(4):539-570.
PMID: 31537750
PMC: 6782023.
DOI: 10.1124/pr.118.017129.
Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice.
Stegbauer J, Thatcher S, Yang G, Bottermann K, Rump L, Daugherty A
J Vasc Surg. 2019; 70(5):1658-1668.e1.
PMID: 30850299
PMC: 6728232.
DOI: 10.1016/j.jvs.2018.11.045.
The Meaning of Mas.
Bader M, Alenina N, Young D, Santos R, Touyz R
Hypertension. 2018; 72(5):1072-1075.
PMID: 30354821
PMC: 6217935.
DOI: 10.1161/HYPERTENSIONAHA.118.10918.
The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).
Santos R, Sampaio W, Alzamora A, Motta-Santos D, Alenina N, Bader M
Physiol Rev. 2018; 98(1):505-553.
PMID: 29351514
PMC: 7203574.
DOI: 10.1152/physrev.00023.2016.
The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
Li X, Zhang J, Zhuo J
Pharmacol Res. 2017; 125(Pt A):21-38.
PMID: 28619367
PMC: 5607101.
DOI: 10.1016/j.phrs.2017.06.005.
Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22.
Karnik S, Singh K, Tirupula K, Unal H
Br J Pharmacol. 2017; 174(9):737-753.
PMID: 28194766
PMC: 5387002.
DOI: 10.1111/bph.13742.
Anti-Inflammatory Action of Angiotensin 1-7 in Experimental Colitis.
Khajah M, Fateel M, Ananthalakshmi K, Luqmani Y
PLoS One. 2016; 11(3):e0150861.
PMID: 26963721
PMC: 4786309.
DOI: 10.1371/journal.pone.0150861.
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].
Karnik S, Unal H, Kemp J, Tirupula K, Eguchi S, Vanderheyden P
Pharmacol Rev. 2015; 67(4):754-819.
PMID: 26315714
PMC: 4630565.
DOI: 10.1124/pr.114.010454.
The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial.
An J, Hwang J, Lee J, Chin H, Kim S, Kim D
PLoS One. 2015; 10(6):e0128632.
PMID: 26098847
PMC: 4476682.
DOI: 10.1371/journal.pone.0128632.